We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$20B
AUM Growth
+$852M
Cap. Flow
-$306M
Cap. Flow %
-1.53%
Top 10 Hldgs %
37.59%
Holding
83
New
9
Increased
25
Reduced
19
Closed
9

Top Sells

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$578M
2
HUM icon
Humana
HUM
+$384M
3
HCA icon
HCA Healthcare
HCA
+$241M
4
C icon
Citigroup
C
+$172M
5
NOV icon
NOV
NOV
+$156M

Sector Composition

Rank Sector Weight
1 Healthcare 32.71%
2 Consumer Discretionary 15%
3 Technology 9.79%
4 Communication Services 8.57%
5 Industrials 7.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
1
Thermo Fisher Scientific
TMO
$209B
$1.43B 7.14%
11,387,265
+11,598
+0.1% +$1.41M
MON
2
DELISTED
Monsanto Co
MON
$1.15B 5.75%
9,618,448
FLEX icon
3
Flex
FLEX
$46.8B
$840M 4.2%
99,698,783
+6,635,000
+7% +$52.5M
THC icon
4
Tenet Healthcare
THC
$20.4B
$700M 3.5%
13,812,831
CYH icon
5
Community Health Systems
CYH
$417M
$652M 3.26%
14,633,492
WOOF
6
DELISTED
VCA Inc.
WOOF
$624M 3.12%
12,800,370
+4,114,200
+47% +$185M
PVH icon
7
PVH
PVH
$4.09B
$581M 2.91%
4,534,423
+427,071
+10% +$51.3M
EBAY icon
8
eBay
EBAY
$48.7B
$547M 2.74%
23,158,366
+11,468,619
+98% +$260M
DG icon
9
Dollar General
DG
$28.1B
$495M 2.48%
7,004,778
-206,537
-3% -$13.4M
ENDP
10
DELISTED
Endo International plc
ENDP
$494M 2.47%
6,851,326
+1,193,000
+21% +$81.7M
AGN
11
DELISTED
Allergan plc
AGN
$474M 2.37%
1,841,869
+124,011
+7% +$31M
PNR icon
12
Pentair
PNR
$10.9B
$468M 2.34%
10,480,827
HRI icon
13
Herc Holdings
HRI
$5.71B
$462M 2.31%
6,178,248
-317,063
-5% -$21.4M
HCA icon
14
HCA Healthcare
HCA
$86.8B
$453M 2.27%
6,178,678
-3,431,881
-36% -$241M
ELV icon
15
Elevance Health
ELV
$82B
$451M 2.26%
3,592,645
-443,800
-11% -$54.8M
DHR icon
16
Danaher
DHR
$137B
$429M 2.15%
7,439,160
PARA
17
DELISTED
Paramount Global Class B
PARA
$416M 2.08%
7,519,648
+3,265,200
+77% +$174M
FNF icon
18
Fidelity National Financial
FNF
$13.9B
$384M 1.92%
16,071,642
+2,471,006
+18% +$52.5M
MHK icon
19
Mohawk Industries
MHK
$9.25B
$362M 1.81%
2,328,002
+1,422,002
+157% +$204M
CAR icon
20
Avis
CAR
$4.99B
$361M 1.81%
5,441,647
+1,497,500
+38% +$85.7M
AET
21
DELISTED
Aetna Inc
AET
$352M 1.76%
3,960,125
-439,910
-10% -$36.9M
TWC
22
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$347M 1.74%
2,283,190
+447,100
+24% +$64.5M
CDNS icon
23
Cadence Design Systems
CDNS
$93.8B
$335M 1.68%
17,652,108
+3,250,000
+23% +$58.3M
BKD icon
24
Brookdale Senior Living
BKD
$3.4B
$321M 1.61%
8,756,030
+2,407,300
+38% +$81.6M
HUM icon
25
Humana
HUM
$43.5B
$317M 1.59%
2,207,844
-2,808,692
-56% -$384M

Similar funds

Glenview Capital Management's Q4 2014 Portfolio in Review

As of Q4 2014, Glenview Capital Management held 83 positions worth $20B, up 4.5% from $19.1B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Glenview Capital Management's Q4 2014 filing shows 9 new, 25 increased, 19 reduced and 9 closed positions. Its largest new stake was Apollo Education Group Inc Class A: 5,396,132 shares worth $184M. The largest sale was Crown Castle, an estimated $578M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Glenview Capital Management's largest Q4 2014 buy was Apollo Education Group Inc Class A: 5,396,132 shares worth $184M.
  • Glenview Capital Management added most to eBay in Q4 2014, an estimated $260M increase.
  • Glenview Capital Management's biggest Q4 2014 reduction was Crown Castle, cutting an estimated $578M.
  • Glenview Capital Management fully exited Citigroup in Q4 2014, selling an estimated $172M.
  • Glenview Capital Management's ten largest holdings make up 38% of its $20B portfolio in Q4 2014.
  • Glenview Capital Management opened 9 new positions and closed 9 in Q4 2014.
  • Glenview Capital Management's portfolio value rose 4.5% quarter-over-quarter to $20B.

Based on Glenview Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.